Wikidata

(Q66400806)

English

Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

clinical trial

In more languages

Statements

short name
CLEAR (English)
0 references
title
A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination With Everolimus or Pembrolizumab Versus Sunitinib Alone in First-Line Treatment of Subjects With Advanced Renal Cell Carcinoma (CLEAR) (English)
0 references
country
Australia
0 references
Austria
0 references
Belgium
0 references
Canada
0 references
France
0 references
Germany
0 references
Greece
0 references
Republic of Ireland
0 references
Israel
0 references
Italy
0 references
Japan
0 references
Netherlands
0 references
Poland
0 references
Spain
0 references
Switzerland
0 references
United Kingdom
0 references
start time
13 October 2016
0 references
end time
24 April 2020
0 references
number of participants
1,050
0 references
research intervention
pembrolizumab
0 references
sirolimus
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q66400806&oldid=2131027420"